Rankings
▼
Calendar
RYTM FY 2012 Earnings — Rhythm Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
RYTM
Rhythm Pharmaceuticals, Inc.
$6B
FY 2012 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$18M
Net Income
-$18M
EPS (Diluted)
$-0.36
Cash Flow
Operating Cash Flow
-$18M
Free Cash Flow
-$18M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$19M
Total Liabilities
$55M
Stockholders' Equity
-$36M
Cash & Equivalents
$12M
← FY 2013
All Quarters
